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Abstract: Necrotic enteritis toxin B (NetB) is a β-pore-forming toxin produced by 
Clostridium perfringens and has been identified as a key virulence factor in the 
pathogenesis of avian necrotic enteritis, a disease causing significant economic damage to 
the poultry industry worldwide. In this study, site-directed mutagenesis was used to 
identify amino acids that play a role in NetB oligomerisation and pore-formation. NetB 
K41H showed significantly reduced toxicity towards LMH cells and human red blood cells 
relative to wild type toxin. NetB K41H was unable to oligomerise and form pores in 
liposomes. These findings suggest that NetB K41H could be developed as a genetic toxoid 
vaccine to protect against necrotic enteritis. 
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1. Introduction 
Necrotic enteritis toxin B (NetB) is a recently identified β-pore-forming toxin (β-PFT) produced  
by Clostridium perfringens [1,2]. This toxin has been identified as a major virulence factor in avian 
necrotic enteritis (NE). According to an estimation in the year 2000, NE is causing an economic 
damage of around 2 billion US dollars a year to the poultry industry worldwide [3]. 
In a previous study, the crystal structure of the NetB heptamer was solved and showed high 
similarity to the structure of the heptamer formed by Staphylococcus aureus alpha-hemolysin (αHL) [4], 
the prototypic member of the related αHL-like β-PFTs family. Proteins belonging to this family are 
organised into three main domains according to their structure and function: rim, stem and β-sandwich. 
The rim domain is essential in mediating binding of the toxin to the target cell membrane, the stem 
domain consists of the characteristic β-hairpin involved in the penetration of the toxin into the 
membrane and formation of the transmembrane β-barrel structure. The β-sandwich domain, rich in  
β-strands, forms the protein backbone with key functions in toxin oligomerisation [5–7]. 
In general, pore-formation by αHL-like β-PFTs is suggested to occur in four-steps: (i) secretion of a 
water-soluble monomeric toxin by the bacterium; (ii) binding of the monomer to the membrane;  
(iii) assembly of the membrane-bound monomers into a multimer; and (iv) formation of a  
membrane-spanning β-barrel pore-structure [8–10]. Extensive mutagenesis studies with αHL have  
led to the identification of several amino acid residues important for toxin oligomerisation and  
pore-formation [11,12]. A pre-pore stage, in which the αHL heptamer is fully assembled, but does not 
penetrate the membrane, has also been well defined [8,13,14]. Like αHL, NetB has been suggested to 
oligomerise into a heptameric structure on the target cell surface upon pore formation [1,4]. However, 
the assembly mechanism is still not well understood. This study was conducted to gain information on 
the functional roles of selected amino acids in NetB oligomerisation and pore-formation. 
2. Results and Discussion 
2.1. Purification of Wild Type NetB and Variants of NetB 
For site-directed mutagenesis, we have not only selected amino acids which are conserved across 
αHL-like β-PFTs (K41, P155 and D156) but also amino acids which, on the basis of the heptameric 
NetB crystal structure, we believe play critical roles in toxicity but are not conserved across αHL-like 
β-PFTs (K71 and D250). The latter residues were also chosen based on their proximity to residues 
found to be functionally important in S. aureus αHL. Mutation of αHL R66 or αHL D254 has been shown 
to reduce binding and hemolysis of rabbit red blood cells (rRBCs) [12]. Variant forms of NetB were made 
as described in the experimental section by site-directed mutagenesis and verified by sequencing. 
Expression and purification of the variant forms of NetB resulted in similar protein yields to wild 
type toxin. The purified proteins were analysed by SDS-PAGE and showed a single band with  
an apparent molecular weight of 38 kDa (Figure 1). SDS-PAGE of purified proteins were performed 
three times and always showed the same protein migration pattern. Far-UV and near-UV circular 
dichroism (CD) spectroscopy analyses revealed very similar spectra and secondary structure contents 
of the NetB variants relative to wild type NetB (Figure 2; Table 1), indicating that NetB variants were 
folded correctly. 
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Figure 1. SDS-PAGE analyses of wild type NetB and variants of NetB. After protein 
purification, wild type NetB and NetB variants were analysed by SDS-PAGE. Lane 1: 
protein marker (molecular mass is indicated in kDa to the left); lane 2: wild type NetB; 
lane 3: NetB K41H; lane 4: NetB K71A; lane 5: NetB P155A; lane 6: NetB D156C; lane 7: 
NetB D250A. 
 
Figure 2. Far-UV and near-UV CD spectra of wild type NetB and variants of NetB. 
 
2.2. Binding and Toxicity of NetB to LMH Cells and hRBCs 
Wild type NetB and NetB variants K41H, K71A, P155A, D156C and D250A were tested for their 
ability to bind to the chicken hepatocellular carcinoma epithelial cell line (LMH). Proteins were 
incubated with LMH cells for 10 min at 37 °C and bound protein measured by an On-cell Western 
assay. Binding data revealed that NetB K41H was significantly impaired in binding to LMH cells, 
showing a reduction of 61% relative to wild type toxin (Figure 3). 
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Table 1. Protein secondary structure contents of wild type NetB and variants of NetB. 
Protein secondary structure contents were estimated based upon the principle component 
regression method embedded within the Grams 32AI/PLS software. 
Protein α-helix (%) β-sheet (%) other (%) 
NetB wt 9.5 32.2 58.3 
NetB K41H 7.2 33.2 59.6 
NetB K71A 7.2 33.2 59.6 
NetB P155A 8.6 32.5 58.9 
NetB D156C 8.7 32.6 58.7 
NetB D250A 9.5 32.2 58.3 
Figure 3. Binding of wild type NetB and variants of NetB to LMH cells. LMH cells were 
grown on 96-well plates and incubated with wild type NetB or variants of NetB (23 μM) 
for 10 min at 37 °C. The degree of binding is shown relative to wild type toxin (100%). 
Graph represents data from four replicates in three independent experiments (data are 
means ± SEM; n = 3). Asterisks indicate a statistically significant difference (***: p < 0.001; 
1-way ANOVA) relative to wild type NetB. 
 
Next, NetB K41H was tested for cytotoxicity towards LMH cells. In a previous study, the dose of 
wild type NetB required to lyse 50% of LMH cells (CT50) was determined as 800 nM [4]. In this study, 
LMH cells were incubated with wild type NetB or NetB K41H at molar concentrations of 4 µM  
(4 × CT50), 8 µM (10 × CT50) or 16 µM (20 × CT50). A statistically significant reduction in 
cytotoxicity between NetB K41H relative to wild type NetB was shown at all toxin concentrations 
tested and even at the maximum molar concentration tested of 16 µM only 41% of the cells were lysed 
by NetB K41H (Figure 4). 
The hemolytic activities of wild type NetB and variants of NetB were compared by determining 
their median hemolytic dose (CT50) towards human RBCs (hRBCs). While wild type NetB showed a 
CT50 of 161 nM, NetB K41H showed a 16-fold reduced cytotoxicity towards hRBCs, with a CT50  
of 2710 nM (Figure 5). No significant differences in CT50 doses were observed for the other NetB 
variants relative to wild type toxin. 
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Figure 4. Comparison of the cytotoxic effect of wild type NetB and NetB K41H towards 
LMH cells. LMH cells were grown on 96-well plates and incubated with wild type NetB or 
NetB K41H at a concentration of 4 µM, 8 µM or 16 µM for 2 h at 37 °C. Cytotoxicity is 
shown relative to the signal of untreated (0%) and lysed cells (100%). Graph represents 
data from three replicates in three independent experiments (data are means ± SEM; n = 3). 
Asterisks indicate a statistically significant difference (***: p < 0.001; 2-way ANOVA) 
relative to wild type toxin. 
 
Figure 5. Hemolysis of hRBCs by wild type NetB and variants of NetB. Two-fold dilution 
series of wild type NetB or variants of NetB were incubated with hRBCs at molar 
concentrations ranging from 20 nM to 10 μM. The required dose to lyse 50% of the cells 
(CT50) was determined after incubation of NetB for 1 h at 37 °C. Graph represents data from 
three independent experiments (data are means ± SEM; n = 3). Asterisks indicate a 
statistically significant difference (***: p < 0.001; 1-way ANOVA) relative to wild  
type NetB. 
 
In order to test if NetB K41H was able to form functional pores, an osmotic protection assay using 
polyethylene glycol (PEG) of different molecular sizes was performed. While hemolysis of 
erythrocytes could only be partially blocked by PEG 300, 26% in the case of wild type toxin and 15% 
in the case of NetB K41H, hemolysis was notably blocked by PEG 1000 by 79% and 77% for wild 
type toxin and NetB K41H, respectively (data not shown). 
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2.3. Oligomerisation and Pore-Formation of NetB 
To test the ability of wild type NetB and NetB K41H to form high molecular weight complexes on 
the liposomal surface, detergent extracted proteins were analysed by size-exclusion chromatography. 
The chromatogram of NetB K41H showed an altered elution profile relative to wild type NetB  
(Figure 6). While most of wild type NetB ran as a high molecular weight complex, NetB K41H was 
mostly present as monomer. 
Figure 6. Size-exclusion chromatography of liposome-bound wild type NetB and NetB 
K41H. Wild type NetB and NetB K41H were mixed with liposomes, followed by detergent 
extraction and run on a Superose-6 size-exclusion chromatography column. 
 
Electron microscopy (EM) was used to visualise NetB on the surface of liposomes. Negatively 
stained liposomes incubated with wild type NetB showed ring-shaped structures, which measured 
approximately 10 nm in diameter (Figure 7A). In contrast, no ring-shaped oligomers were observed for 
NetB K41H (Figure 7B). 
A calcein release assay was performed in order to test if wild type NetB and NetB K41H were able 
to form pores on liposomes. When wild type NetB was incubated with liposomes, calcein was released 
in a dose-dependent manner and over 64% of the loaded calcein was released at a toxin molar 
concentration of 1.05 µM (Figure 8). However, no calcein release was observed when NetB K41H was 
incubated with liposomes, even at the maximum molar concentration tested of 10.5 µM corresponding 
to a 500:1 NetB heptamer/liposome ration. 
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Figure 7. Electron microscopy of liposome-bound wild type NetB and NetB K41H. Wild 
type NetB and NetB K41H were mixed with liposomes and samples were negatively 
stained with 2% (w/v) aqueous uranyl acetate and observed using an FEI Tecnai F20 
transmission electron microscope. (A) wild type NetB; (B) NetB K41H. Arrows indicate 
wild type NetB oligomers in panel A and NetB K41H monomers in panel B. 
 
(A) (B) 
Figure 8. Calcein release assay of wild type NetB and NetB K41H. Calcein loaded 
liposomes were incubated with wild type NetB and NetB K41H at various molar 
concentrations and percentage of calcein release was measured after 1 h at 37 °C.  
Graph represents data from three replicates in three independent experiments (data are 
means ± SEM; n = 3). 
 
3. Discussions 
In a previous study, we were able to show that amino acid mutations within the rim loops of NetB 
resulted in a significant decrease in toxicity due to reduced binding to target cells [4]. This study used 
site-directed mutagenesis within the β-sandwich domain of NetB to identify amino acid residues 
important for toxin oligomerisation and pore-formation. 
NetB variants K71A, P155A, D156C and D250A did not show altered binding to LMH cells or 
hemolysis on hRBCs. Previous studies revealed that mutation of S. aureus αHL (D152C) abolished 
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lytic activity towards rRBCs [12] and mutation of the corresponding residue in C. perfringens beta 
toxin (D167N) made the toxin unstable [15]. Surprisingly, mutation of the corresponding amino acid in 
NetB (D156C) did not affect activity, suggesting that this residue plays a different role in NetB. 
NetB K41H showed significantly reduced binding and toxicity towards LMH cells and reduced 
hemolysis towards hRBCs relative to wild type toxin. Osmotic protection assays on hRBCs indicate 
that NetB K41H toxicity was mediated by the formation of a pore as hemolysis could be blocked  
by the use of PEG 1000 in a similar manner to wild type toxin. In contrast, no pore-formation was 
observed when NetB K41H was mixed with liposomes, possibly due to the protein-free composition or 
different fluidity of the liposomal bilayer. Membrane lipid composition and membrane fluidity have 
been shown to be an important factor for NetB oligomerisation and pore-formation [4]. It is also 
possible that pore-formation could have been achieved by using higher toxin concentrations. However, 
EM of liposome-bound NetB K41H indicate that this variant form of NetB was less efficient in 
binding and unable to oligomerise on the liposomal surface. 
According to the solved multimeric NetB structure [4], the side chains of K41 are located in the 
monomer-monomer interface and thus may be involved in forming a stabilising salt bridge with the 
adjacent monomer. Amino acid mutation at an equivalent position in S. aureus γ-hemolysin (T28D) 
resulted in a toxin with no pore-forming activity on liposomes or human leukocytes and only slight 
hemolytic activity towards rRBCs [16]. Various point mutations of the equivalent amino acid position 
in S. aureus αHL (H35C, H35I, H35L, H35N, H35P, H35Q, H35R, H35S, H35T and H35W) have 
been shown to significantly reduce hemolytic activity towards rat and rabbit RBCs [12,17,18]. Valeva 
and co-workers [8,19] demonstrated that H35 is a key residue for transition of S. aureus αHL from the 
pre-pore to the transmembrane pore complex by facilitating the insertion of the stem domain into the 
membrane. Position K41 may play a similar role for NetB oligomerisation and pore-formation. 
In a previous study, we showed that vaccination of chicken with NetB W262A was able to induce a 
specific immune response to NetB and significantly protect animals against NE [20]. In a similar 
manner, NetB K41H may have the potential to be protective when used as a genetic toxoid vaccine.  
A S. aureus αHL mutant protein in the equivalent amino acid position (H35L) has been tested in an 
intraperitoneal murine model and showed no lethal activity [21]. In addition, passive immunisation of 
mice with rabbit antiserum against αHL H35L led to significant protection against lethal challenge  
of wild type toxin. A recent study confirmed protection against S. aureus mediated pneumonia by 
immunisation with αHL H35L [22,23]. 
4. Experimental Section 
4.1. Expression and Purification of Wild Type NetB 
Expression of wild type NetB was carried out as described previously in E. coli TOP10 cells [4].  
In summary, E. coli cells carrying the pBAD-NetB expression vector were grown in terrific broth (TB) 
supplemented with ampicillin (100 μg/mL) at 37 °C and shaken at 300 rpm. For protein expression, 
cultures were induced for 6 h by adding arabinose to a final concentration of 0.02% (w/v) at an optical 
density (OD595nm) of 0.5. Bacterial cells were harvested by centrifugation, lysed enzymatically using 
BugBuster (EMD Millipore, Billerica, MA, USA) and NetB was purified by Ni-NTA chromatography 
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columns (GE Healthcare, Little Chalfont, UK) according to manufacturer’s instructions. Buffer was 
exchanged by size-exclusion chromatography using PD-10 desalting columns (GE Healthcare, Little 
Chalfont, UK) equilibrated with Tris-buffered saline (TBS; 20 mM Tris pH 7.5, 150 mM NaCl) and 
protein concentrations were measured with a UV-Vis spectrophotometer (Thermo Scientific, 
Cramlington, UK). 
4.2. Design and Purification of Variant Forms of NetB 
The following variant forms of NetB were made by site-directed mutagenesis: K41H, K71A, 
P155A, D156C and D250A. To keep any possible structural changes to a minimum, NetB K41 was 
replaced by histidine (the equivalent amino acid in S. aureus αHL) and NetB D156 by cysteine as 
replacement of the equivalent position in S. aureus αHL (D152) by cysteine resulted in a soluble 
protein [12]. None-previously mutated positions in related αHL like PFTs (K71, P155 and D250) were 
replaced by alanine. All amino acid numbering corresponds to prototoxin with the 30 amino acid  
N-terminal signal peptide sequence removed (UniProt accession number: A8ULG6). Mutants were 
made with the QuikChange II site-directed mutagenesis Kit (Stratagene, Santa Clara, CA, USA) and 
verified by DNA sequencing (Source BioScience, Cambridge, UK). NetB variants were expressed and 
purified as described above for wild type NetB. 
4.3. CD Analyses 
Protein integrity was assessed by far-UV and near-UV CD measurements at the Biomolecular 
Spectroscopy Centre, King’s College London, UK. CD Spectra were acquired on the Chirascan Plus 
spectrometer (Applied Photophysics, Leatherhead, UK) using either 10 mm or 0.5 mm rectangular 
cells in the regions of 270–290 nm or 200–260 nm, respectively. The following parameters were set: 1 
nm spectral bandwidth, 0.5 nm step-size and 1.5 s instrument time-per-point. Throughout the 
experiment, the instrument was flushed continuously with pure evaporated nitrogen. All CD spectra 
were performed at room temperature and buffer baseline corrected. The far-UV CD spectra were 
normalised against protein concentration and path length and expressed as molar CD (Δε). For better 
presentation, far-UV CD spectra were smoothed with a window factor of 4, using the Savitzky-Golay 
method [24]. Protein secondary structure contents were estimated based upon the principle component 
regression method embedded within the Grams 32AI/PLS software (Adept Scientific, Letchworth 
Garden City, UK). 
4.4. SDS-PAGE Analyses 
Protein purity of wild type NetB and variants of NetB was analysed by SDS-PAGE on precast  
4%–12% acrylamide-bisacrylamide gels (Invitrogen, Paisley, UK). All samples were heated prior to 
loading at 70 °C for 10 min in NuPAGE LDS sample buffer (Invitrogen). Each gel lane was loaded 
with 1 µg of protein. Gels were run in MES running buffer (Invitrogen) for 45 min at 200 V and 
stained with SimplyBlue (Invitrogen). 
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4.5. On-Cell Western™ Assay 
The ability of wild type NetB and variants of NetB to bind to the chicken hepatocellular carcinoma 
epithelial cell line (LMH; ATTC: CRL-2117) was tested by an On-cell Western™ assay using the 
Odyssey CLx infrared imaging system (Li-Cor, Lincoln, USA). LMH cells were grown in 
Waymouth’s MB 752/1 medium (Invitrogen) supplemented with 10% fetal calf serum at 37 °C in a 5% 
CO2 incubator to 70%–80% confluency on 96-well plates and fixed with 4% formaldehyde for 20 min 
at room temperature. After washing the cells three times with TBS, cells were incubated with NetB at a 
concentration of 23 μM for 10 min at 37 °C in a 5% CO2 incubator. Cells were then washed three times 
with TBS and blocked with Odyssey blocking buffer (Li-Cor) for 1.5 h at room temperature. Cells 
were then incubated with an anti-Xpress antibody (Invitrogen; 1:1000) overnight at 4 °C. After 
washing three times with TBS, cells were incubated with IRdye 800CW goat anti-mouse (Li-Cor; 
1:800) secondary antibody for 1 h at room temperature. Cells were washed three times with TBS and 
fluorescence was measured by the Odyssey CLx infrared scanner (Li-Cor). 
4.6. Cytotoxic Effect of NetB on LMH Cells 
The cytotoxic activity of wild type NetB or NetB K41H towards LMH cells was tested using the 
CytoTox96 kit (Promega Hemel Hempstead, UK). LMH cells were grown on 96-well plates as 
described above and incubated with 4 µM, 8 µM or 16 μM of NetB for 2 h at 37 °C. Control cells were 
incubated with Waymouth’s medium to determine the base line (0% lysis) or cells were freeze-thawed 
to determine total cell lysis (100% lysis). Cytotoxicity is shown as percentage relative to the controls. 
4.7. Hemolysis Assay 
Hemolysis assays with wild type NetB and variants of NetB were performed using human red blood 
cells (hRBCs) as described previously [4]. In summary, two-fold dilution series of NetB in TBS were 
made in a 96-well microtiter plate and hRBCs (≈4.6 × 106 cells/mL) were then added to each well 
leading to molar concentrations of NetB ranging from 20 nM to 5 μM. Hemolysis was determined  
by measuring absorption at 595 nm after 1 h at room temperature with the iMark microplate reader 
(Bio-Rad Hemel Hempstead, UK) and using the Microplate Manager 6.0 software (Bio-Rad). The 
controls consisted of TBS as the negative control for 0% hemolysis and 2% (v/v) Triton X-100 as the 
positive control for 100% hemolysis. The median hemolytic dose (CT50) for causing 50% hemolysis 
was calculated by using the GraphPad Prism software 5.01 (GraphPad Software, La Jolla, CA, USA). 
4.8. Osmotic Protection Assay 
Osmotic protection assays with wild type NetB and NetB K41H were performed using polyethylene 
glycol (PEG) of different molecular sizes. Therefore, hRBCs were mixed with PEG 300 or PEG 1000 
at a final concentration of 30 mM and incubated with the respective CT50 concentration of wild type 
NetB or NetB K41H. Percentage osmotic protection was calculated based on the cytotoxicity of wild 
type NetB (0%) in the absence of PEG. 
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4.9. Binding and Oligomerisation of NetB to Liposomes 
Lipids (Avanti polar lipids, Alabaster, AL, USA) were prepared by mixing 
dioleoylphosphotidylcholine (DOPC), egg phosphatidylglycerol (Egg PG) and cholesterol at a ratio of 
4:1:5 as described previously [4]. To allow binding and oligomerisation, wild type NetB and NetB 
K41H were mixed with liposomes at a protein to lipid weight ratio of 1:3 and incubated at 37 °C for  
1 h. NetB was extracted from liposomes in TBS buffer containing 40 mM hexaethylene glycol 
monodecyl ether (C10E6) at 4 °C overnight. Unsolubilised material was removed by centrifugation at 
16,000 g for 30 min at 7 °C. Detergent-solubilised NetB was analysed by SDS-PAGE and run on a  
20 mL Superose 6 size-exclusion chromatography column (GE Healthcare). 
4.10. Electron Microscopy 
Wild type NetB or NetB K41H was mixed with liposomes as described above and analysed  
by electron microscopy (EM). Samples were prepared for EM by applying 5 µL of sample onto 
carbon-coated grids that had been previously glow-discharged and incubated for 60 s. Excess liquid 
was blotted off and grids were stained by addition of 5 µL of 2% (w/v) aqueous uranyl acetate. 
Samples were observed on a Tecnai F20 EM (FEI, Hillsboro, OR, USA) operating at an accelerating 
voltage of 200 kV. 
4.11. Calcein Release Assay 
To measure NetB pore-formation, liposomes were filled with calcein as described previously [4] 
and incubated with increasing molar concentrations of wild type NetB and NetB K41H (0.21 µM,  
1.05 µM, 5.25 µM and 10.5 µM) at 37 °C for 1 h. The amount of released calcein was measured using 
a FluoroMax-3 fluorometer (Jobin Yvon Horiba, Edison, NJ, USA) with an excitation and emission 
wavelength of 495 nm and 515 nm, respectively. Calcein release (%) was calculated as follows: 
Calcein release = (Ffinal − F0)/(Fmax − F0) × 100 (1)
Ffinal is the fluorescence measured after incubation with the toxin, F0 is the background fluorescence 
in the absence of toxin and Fmax is the fluorescence after addition of 1% (v/v) of Triton X-100. 
5. Conclusions 
This study showed that K41 is a key amino acid residue for NetB oligomerisation and  
pore-formation. As there is no NetB-based vaccine available so far, NetB K41H may have the potential 
to be protective when used as a genetic toxoid vaccine against NE. 
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